“You’re right, Vivian,” I said softly.
Both women blinked, caught off guard by my lack of resistance.
“I am exhausted,” I continued, reaching into the pocket of my lab coat and pulling out my favorite Montblanc pen. I opened the folder. “Two million is a lot of money. And honestly, dealing with the corporate bureaucracy of L’Éclat sounds miserable.”
I flipped to the signature page. I didn’t read the non-compete. I didn’t read the NDA. I knew exactly what they contained, and I knew exactly why they didn’t matter in the slightest.
I signed my name in a smooth, looping script, closed the folder, and pushed it back across the glass.
“I’ll have my office cleared out by five o’clock,” I said, standing up. “Good luck with the L’Éclat acquisition, Serena. I’m sure your Instagram followers will be thrilled.”
Serena beamed, already pulling up the camera on her phone. “Thanks, Harpie! We’ll send you a gift basket when the deal closes.”
I walked out of the boardroom, took the elevator down to the sub-basement, and entered my sanctuary. The lab was humming with the quiet whir of centrifuges and climate-controlled refrigerators. I didn’t take any of the equipment. I didn’t take any of the physical product.
I opened the heavy, fireproof safe in the corner of my office. Inside was a stack of leather-bound notebooks—my original formulation logs. I placed them into a waterproof duffel bag. Then, I logged onto my computer and wiped my personal hard drive, leaving only the standard operational protocols on the servers.
By 4:45 PM, I was walking out of the building. I deposited the two-million-dollar cashier’s check into my personal bank account. Then, I drove to the airport, bought a first-class ticket to the Amalfi Coast, and turned my phone off.
The countdown had begun.
To understand the absolute, unmitigated disaster Vivian and Serena had just triggered, you have to understand the arrogance of non-technical executives.
Vivian thought business was about branding, packaging, and schmoozing at galas. She never bothered to read the dry, dense legal paperwork that governed the actual mechanics of the company. She assumed that because I worked for Aura Botanica, Aura Botanica owned everything I created.
She was wrong.
Seven years ago, when I first synthesized the Luminescence compound, the company was nearly bankrupt. We couldn’t afford to pay a patent attorney. So, I paid for the patent filings out of my own pocket, using my own personal savings.
Legally, the patent for the Luminescence active ingredient, and the precise chemical manufacturing processes required to stabilize it, did not belong to Aura Botanica. They belonged to Harper Ellis.
I had subsequently drafted a boilerplate, non-exclusive intellectual property license agreement, granting Aura Botanica the right to manufacture and sell my formulas in exchange for a yearly licensing fee of one dollar. My father had signed it, grateful for my help. Vivian had never even known it existed, because it was buried in a filing cabinet under “Miscellaneous Vendor Agreements.”
And according to Section 4, Clause B of that agreement, the license was immediately rendered null and void upon my termination, resignation, or the transfer of majority ownership of the company.
When I signed Vivian’s buyout agreement, I didn’t just resign. I legally stripped Aura Botanica of the right to manufacture, sell, or reproduce every single product in their portfolio.
I spent the next three weeks in Positano, Italy. I drank Limoncello, ate fresh pasta, and read novels on a sun-drenched terrace overlooking the Tyrrhenian Sea. I checked my bank account to ensure the two million dollars had cleared. It had.
On day twenty-four of the forty-five-day due diligence period, I finally turned my American cell phone back on.
It nearly vibrated out of my hand.
There were one hundred and forty-two missed calls. Eighty of them were from Vivian. The rest were from Serena, our corporate lawyers, and various unknown international numbers. I opened my voicemail and put the phone on speaker while I poured myself an espresso.
“Harper! Pick up the phone right now! The lawyers from L’Éclat are tearing the server room apart asking for the patent assignments! Where are the IP files? Call me back immediately!” – Vivian (Day 18)
“Harpie, seriously, this isn’t funny. L’Éclat just paused the acquisition. They’re saying the formulas aren’t in the data room. You need to email me the patents right now. My entire brand ambassadorship is riding on this!” – Serena (Day 20)
“Harper, this is Vivian. Our lawyers just found the vendor agreement. What the hell is this? You don’t own the company’s formulas! You made them on company time! We will sue you into oblivion! You are destroying a hundred-and-fifty-million-dollar deal! Answer the goddamn phone!” – Vivian (Day 22)
I smiled, taking a slow sip of my espresso. The bitterness of the coffee was perfectly balanced.
L’Éclat was not a foolish company. Before dropping nine figures on a skincare brand, their army of corporate attorneys would naturally conduct a forensic audit of the intellectual property. They didn’t care about Serena’s Instagram followers. They cared about the chemical patents. And they had just discovered that they were about to pay one hundred and fifty million dollars for empty glass jars and a logo.
I didn’t call Vivian back. Instead, I scrolled through my emails and found the one I had been waiting for.
It was from Jean-Luc Devereux, the Global Head of Mergers and Acquisitions for L’Éclat.
Subject: Urgent Discussion regarding Aura Botanica Intellectual Property.Ms. Ellis, it has come to our attention during our due diligence process that you are the sole patent holder for the Luminescence formulas. We are highly motivated to resolve this impasse. Are you available for a meeting?
I replied with a single sentence: I am currently in Italy, but I will be returning to New York on Thursday. We can meet then. Do not inform Vivian Ellis of our communications.
Popular Posts
→- 1
- 2
- 3
- 4
Recently Viewed
Stories you read recently will appear here.



